在脏疾病中通过5-甲基三甲进行膜保护
Jonah P Gutierrez1, Tram N Diep1, Shaona Niu1
1Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
5-甲基托 (5-MTP),托的代谢物,显示出对损伤的保护作用. 在慢性病 (CKD) 中,低血清5-MTP水平表明其作为生物标志物和治疗剂的潜力.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 代谢学 代谢学 代谢学
- 药理学 药理学是指药理学的学科.
背景情况:
- 病呈现复杂的病理,是严重的健康问题.
- 研究正在探索治疗点,以保护功能免受各种有害条件的影响.
- 5-甲基 (5-MTP) 是基的代谢物,目前正在研究其在健康中的作用.
研究的目的:
- 审查5-甲基酸 (5-MTP) 对损伤的保护作用.
- 探索5-MTP作为脏疾病的生物标志物和治疗剂的潜力.
主要方法:
- 关于5-MTP和损伤的已发表研究的综述.
- 对动物损伤模型的分析 (叶酸,LPS,UUO,缺血/再输液).
- 检查5-MTP脏保护作用的潜在机制.
主要成果:
- 在患有慢性病 (CKD) 的患者中,血清5-MTP水平降低.
- 外源性5-MTP在动物损伤的各种模型中显示出脏保护作用.
- 机制包括抗氧化,抗炎,抗纤维效应和增强的线粒细胞吸收.
结论:
- 5-MTP作为CKD的生物标志物和潜在的治疗化合物显示出希望.
- 需要进一步的研究来探索5-MTP在各种损伤模型中,并研究增加内源性5-MTP水平的方法.
- 5-MTP与其他疗法的协同效应需要研究.
更多相关视频
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
07:06Isolation of Primary Human Proximal Tubule Epithelial Cells and Their Use in Creating a Microphysiological Model of the Renal Proximal Tubule
Published on: May 9, 2025
相关概念视频
Chronic Kidney Disease III: Interprofessional Care
Renal Drug Excretion: Tubular Secretion
Renal Drug Excretion: Overview
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Renal Drug Excretion: Tubular Reabsorption
Drug Elimination by Renal Route: Tubular Secretion
